NIPA 1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis

Department of Neurology and Department of Neuroloscience and Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands, Department of Neurology, University Hospital Leuven, University of Leuven, Leuven, Belgium, Vesalius Research Center, VIB, Leuven, Belgium, Department of Neurology, University of Ulm, Ulm, Germany, Department of Neurology, Charité University Hospital, Humboldt-University, Berlin, Germany, Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany and Hubrecht Institute for Developmental Biology and Stem Cell Research, Royal Netherlands Academy of Sciences and University Medical Center Utrecht, The Netherlands

[1]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[2]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[3]  A. Gitler,et al.  Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis , 2011, Neurology.

[4]  B. Dubois,et al.  Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2 , 2011, Neurology.

[5]  P. Andersen,et al.  Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. , 2011, Human molecular genetics.

[6]  Ewout J. N. Groen,et al.  A large genome scan for rare CNVs in amyotrophic lateral sclerosis. , 2010, Human molecular genetics.

[7]  A. Al-Chalabi,et al.  An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  John Q. Trojanowski,et al.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.

[9]  Ewout J N Groen,et al.  Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.

[10]  Xinnan Wang,et al.  The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling , 2009, Human molecular genetics.

[11]  G. Rouleau,et al.  Molecular mechanisms underlying polyalanine diseases , 2009, Neurobiology of Disease.

[12]  Emmanuel J. Botzolakis,et al.  Hereditary Spastic Paraplegia-Associated Mutations in the NIPA1 Gene and Its Caenorhabditis elegans Homolog Trigger Neural Degeneration In Vitro and In Vivo through a Gain-of-Function Mechanism , 2008, The Journal of Neuroscience.

[13]  E. Cuppen,et al.  Improved generation of rat gene knockouts by target-selected mutagenesis in mismatch repair-deficient animals , 2008, BMC Genomics.

[14]  Xinnan Wang,et al.  Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules , 2007, Nature Neuroscience.

[15]  G. Bernardi,et al.  Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia , 2006, Movement disorders : official journal of the Movement Disorder Society.

[16]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[17]  Edwin Cuppen,et al.  Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis , 2006, Pharmacogenetics and genomics.

[18]  Jiandong Sun,et al.  Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families , 2005, Human mutation.

[19]  D. Kirschner,et al.  Poly-(L-alanine) expansions form core beta-sheets that nucleate amyloid assembly. , 2005, Proteins.

[20]  M. Simpson,et al.  A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia , 2005, Neurogenetics.

[21]  J. Fink,et al.  NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). , 2003, American journal of human genetics.

[22]  D. Nickerson,et al.  PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. , 1997, Nucleic acids research.